January 24, 2022
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
Media
January 21, 2022
Elsa Science appoints new Chairman of the Board, Niklas Eklund
January 21, 2022
Oncopeptides rescinds voluntary withdrawal of Pepaxto in the US – no intent to market in the US at this time
January 19, 2022
Nordic Nanovector ASA – Private placement of new shares successfully placed
January 18, 2022
Xeris Biopharma Reaffirms 2021 Guidance and Provides Business Update
January 17, 2022
Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan
January 13, 2022
BONESUPPORT signs distribution agreement with OrthoPediatrics
January 13, 2022
Oncopeptides phase 3 OCEAN study published in the Lancet Haematology
January 12, 2022
Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway
January 11, 2022
Fusion Pharmaceuticals Announces Research Collaboration With 48Hour Discovery To Develop Peptide-Based Radiopharmaceuticals